A CaV2.1 N-terminal fragment relieves the dominant-negative inhibition by an Episodic ataxia 2 mutant. - Dahimene S; Page KM; Nieto-Rostro M; Pratt WS; D'Arco M; Dolphin AC (Neurobiology of disease, 2016)